Ovine anti-rabies antibody production and evaluation

Comparative Immunology, Microbiology and Infectious Diseases

Volumn 32, Issue 1, 2009, Pages 9-19

  Redwan, EL Rashdy M ^a   Fahmy, Ali ^b   Hanafy, Amr EL ^a   EL Baky, Nawal Abd ^a   Sallam, Sobhy M A ^c  

^a City of Scientific Research and Technological Applications   (Egypt)

^b VACSERA   (Egypt)

^c Alexandria University   (Egypt)

Author keywords

Anti rabies; Immunogenicity; Neutralization; Ovine; Purified antibody; Rabies

Indexed keywords

IMMUNOGLOBULIN G; OCTANOIC ACID; RABIES IMMUNOGLOBULIN; RABIES VACCINE;

ANIMAL EXPERIMENT; ANTIBODY PRODUCTION; ANTIBODY TITER; ARTICLE; BIOREACTOR; CONTROLLED STUDY; DRUG PURIFICATION; FEMALE; HUMAN; HUMAN CELL; IMMUNIZATION; IMMUNOGENICITY; MOUSE; NONHUMAN; SHEEP; VACCINE PRODUCTION; VERO CELL; VIRUS NEUTRALIZATION;

ANIMALS; ANTIBODIES, VIRAL; CAMELS; CERCOPITHECUS AETHIOPS; CROSS REACTIONS; FEMALE; HORSES; HUMANS; IMMUNIZATION; IMMUNIZATION, PASSIVE; IMMUNOGLOBULIN G; MICE; NEUTRALIZATION TESTS; RABBITS; RABIES; RABIES VACCINES; RABIES VIRUS; SHEEP, DOMESTIC; VERO CELLS;

ANIMALIA; EQUIDAE; OVIS; OVIS ARIES;

EID: 56149115293     PISSN: 01479571     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cimid.2007.11.004     Document Type: Article

References (24)

1. Sloan S.E., Hanlon C., Weldon W., Niezgoda M., Blanton J., Self J., et al. Identification and characterization of a human monoclonal antibody that potently neutralizes a broad panel of rabies virus isolates. Vaccine 25 (2007) 2800-2810
2. Karliner J.S., and Belaval G.S. Incidence of reactions following administration of anti-rabies serum: a study of 526 cases. J Am Med Associ 193 (1965) 359-362
3. Landon J., Chard T., and Coxon R.E. An introduction to the clinical applications of antibodies. In: Landon J., and Chard T. (Eds). Therapeutics antibodies (1995), Springer-Verlag 1-32
4. Wilde H., Chomchey P., Prakongsri S., and Punyaratabandhu P. Safety of equine rabies immune globulin. Lancet 2 8570 (1987) 1275
5. Wilde H., Chomchey P., Prakongsri S., Puyaratabandhu P., and Chutivongse S. Adverse effects of equine rabies immune globulin. Vaccine 7 (1989) 10-11
6. Wilde H., and Chutivongse S. Equine rabies immune globulin: a product with an undeserved poor reputation. Am J Trop Med Hyg 42 (1990) 175-179
7. WHO Expert Committee on Biological Standardization. Forty-third report. Geneva. Requirements for the collection, processing and quality control of blood, blood components and plasma derivatives. World Health Organization; 1984. WHO Tech. Report Ser. No. 840, annex 2.
8. WHO Expert Committee on Rabies. Eighth report. Geneva, World Health Organization; 1992. WHO Tech. Report Ser. No. 824, annex 2.
9. Redwan E.M., Khalil A., and EL-Dardiri Z.Z. Production and purification of ovine anti-tetanus antibody. Comp Immunol Microbiol Infect Dis 28 (2005) 167-176
10. Hickey A.R., Wenger T.L., Carpenter V.P., Tilson H.H., Hlatky M.A., Furberg C.D., et al. Digoxin Immune Fab therapy in the management of digitalis intoxication: safety and efficacy results of an observational surveillance study. J Am Coll Cardiol 17 (1991) 590-598
11. Redwan E.R. Comparison between therapeutic antitoxin F(ab)2 fractionated with ammonium sulfate and caprylic acid. J Immunoassay Immunochem 27 (2006) 319-329
12. El-karamany R.M. Production in Vero cells of an inactivated rabies vaccine from strain FRV/K for animal and human use. Acta Virol 31 (1987) 321-328
13. Reed S., and Muench L. A simple method of estimating 50% end point. Am J Hyg 27 (1938) 443-497
14. Mohamed A.F., Kaschf A.H., Reda I.M., Tantawy H.M., and Aly R.H. Biological activity of Tubercle Bacilli (BCG) and its related immunogenicity. Egyptian J Med Microbiol 6 (1997) 157-162
15. Mohamed A.F., Zaki M.F., and El-Karamany R.M. Biological and hematological studies post rabies virus infection: clinical view. J Union Arab Biol Cairo 9 (1998) 97-110
16. Mohamed A.F., Moustafa A.S., Amer A., and El-Karamany R.M. Experimental preparation of Vero cell rabies vaccine and related anti-rabies immunoglobulin in horses for human use. Egyptian J Med Microbiol 11 (2002) 147-150
17. Fitzgerald E.A., and Rastogi S.C. A collaborative study to establish an International Standard Rabies immunoglobulin of human origin. J Biol Stand 13 (1985) 327-333
18. Goel S.K., Sharma S., and Singh U.S. Antibody response to purified chick embryo cell vaccine in equines for production of equine rabies immune globulin. Biologicals 31 (2003) 233-236
19. Crawford R.J., Morgan M., and Mitchell R. A regional programme to collect plasma for preparation of human immunoglobulin anti-rabies. J Clin Pathol 33 (1980) 180-182
20. Chantanakajornfung A., Naraporn N., Khumphai W., Bejavongkulchai M., Mitmoonpitak C., and Wilde H. A study of human rabies immune globulin manufactured by the Thai Red Cross. Vaccine 17 (1999) 979-981
21. Hatta H., Tsuda K., Akachi S., Kim M., and Yamamoto T. Productivity and some properties of egg yolk antibody (IgY) against human rotavirus compared with rabbit IgG. Biosci Biotechnol Biochem 57 (1993) 450-454
22. Motoi Y., Sato K., Hatta H., Morimoto K., Inoue S., and Yamada A. Production of rabies neutralizing antibody in hen's eggs using a part of the G protein expressed in Escherichia coli. Vaccine 23 (2005) 3026-3032
23. Landon J., and Smith D.C. Development of novel antivenoms based on specific ovine Fab. In: Bon C., and Goyffon M. (Eds). Envenomings and Their Treatments (1996), Lyon, Foundation Marcel Me'rieux France 173-180
24. Herrera M., León G., Segura A., Meneses F., Lomonte B., Chippaux J.P., et al. Factors associated with adverse reactions induced by caprylic acid-fractionated whole IgG preparations: comparison between horse, sheep and camel IgGs. Toxicon 46 (2005) 775-781